Astrazeneca Pharma India standalone net profit rises 41.09% in the September 2025 quarter
(08 Nov 2025)

Back
Net profit of Astrazeneca Pharma India rose 41.09% to Rs 54.22 crore in the quarter ended September 2025 as against Rs 38.43 crore during the previous quarter ended September 2024. Sales rose 37.03% to Rs 559.09 crore in the quarter ended September 2025 as against Rs 408.00 crore during the previous quarter ended September 2024.

ParticularsQuarter Ended
Sep. 2025Sep. 2024% Var.
Sales559.09408.00 37
OPM %13.4512.88 -
PBDT80.6860.35 34
PBT78.1151.03 53
NP54.2238.43 41

Copyright © 2026 Arihant Capital Markets Ltd. All rights Reserved.

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

x
  • QR-CodeNew